Igc Pharma Inc IGC

$0.27 +0.00 (1.81%)

Valuation

Market cap
27,914,000
Revenue TTM
$1,271,000
Net income TTM
$-7,121,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.18

Trading

Volume
633,200
Avg volume
760,922
Day's range
$0.27 – $0.28
Shares out
103,384,000
Stochastic %K
27%
Beta
0.47
Analysts
Sell
Price target
$4.50

Price

Company profile

IGC Pharma, Inc., a clinical stage pharmaceutical company, develops novel therapeutic candidates for neuropsychiatric and neurodegenerative disorders, with a primary focus on Alzheimer's disease in the United States and Colombia. The company's lead product is IGC-AD1 that is in Phase II clinical trial for the treatment of agitation in dementia due to Alzheimer's. Its pre-clinical stage product candidate includes TGR-...

Show more

IGC Pharma, Inc., a clinical stage pharmaceutical company, develops novel therapeutic candidates for neuropsychiatric and neurodegenerative disorders, with a primary focus on Alzheimer's disease in the United States and Colombia. The company's lead product is IGC-AD1 that is in Phase II clinical trial for the treatment of agitation in dementia due to Alzheimer's. Its pre-clinical stage product candidate includes TGR-63 and IGC-M3 to treat Alzheimer's disease. In addition, the company develops MINT-AD, an AI-driven assistant for healthcare providers. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. IGC Pharma, Inc. was incorporated in 2005 and is headquartered in Potomac, Maryland.

Industry
Biotechnology
Sector
Healthcare
Phone
301 983 0998
Website
https://igcpharma.com
Address
10224 Falls Road, Potomac, United States

Latest news

Stocktwits

Shawshank_book_keeper Oct 3, 9:51 PM
$IGC Thc and melatonin.. it’s going to work on the Alzheimer’s patients!!!
0 replies
NVDAMillionaire Oct 2, 8:56 PM
$IGC Great piece that accurately captures IGC's current position. So if you want to refresh your understanding of IGC or learn about IGC for the first time, this is essential reading. https://everyticker.com/quote/IGC/analysis/igc-pharma-s-binary-gamble-a-phase-2-readout-in-a-post-auvelity-world-nasdaq-igc
0 replies
RocketQueen Oct 2, 2:46 AM
$IGC hidden gem waiting to be discovered.
0 replies
InfiniteSpace Oct 1, 11:50 PM
$IGC is this ever going to move!!
1 replies
_jaydub_ Oct 1, 7:58 PM
$IGC lol
0 replies
Makethatmoneyson Oct 1, 5:36 PM
$IGC
0 replies
NewsAndFilings Oct 1, 12:47 AM
7 Biotechs $IBRX $PACB $IGC $VIVS to Watch in 2026 https://thestreetreports.com/7-biotechs-ibrx-pacb-igc-vivs-to-watch-in-2026/
0 replies
Makethatmoneyson Sep 30, 6:02 PM
$IGC
0 replies